Sorry, there was a problem.

An unexpected error occurred and your request couldn't be handled. Please call a Dignity Health representative at
(844) 274-8497
OR
Chat with us here.

Reference code:

Transcatheter Aortic Valve Replacement (TAVR)


Dignity Health Heart and Vascular Institute is home to one of the largest and most recognized cardiovascular care teams in the state and includes the multidisciplinary TAVR team which has extensive experience, performing more than 400 cases. The TAVR physicians are trained to implant various FDA-approved devices. We offer additional technology through clinical research trials.

TAVR Procedure at Dignity Health Heart and Vascular Institute

Aortic Stenosis is a progressive narrowing of the aortic valve resulting in reduction of blood flow out of the heart. TAVR is a minimally invasive procedure that treats aortic stenosis without requiring open heart surgery. The valve is placed on a catheter, inserted into an artery and advance to the narrowed aortic valve for deployment. TAVR is FDA-approved for patients considered intermediate to high-risk for surgical aortic valve replacement.

Benefits of TAVR

  • Faster recovery times
  • Less pain
  • Improvement in quality of life

What to Expect During the TAVR Procedure

During TAVR, your surgeon will place the valve on a catheter which is inserted into an artery in the groin, rather than through an opening in the chest. The valve is threaded inside the faulty aortic valve and inflated. TAVR patients typically recover faster with less pain than patients undergoing open chest valve replacement.

 

In addition, Dignity Health Heart and Vascular Institute is a select site for TAVR clinical research, offering the newest valve designs, deployment methods, and access to a randomized trial for low risk patients who may not otherwise be eligible for TAVR.

 

Mercy General Hospital is now participating in a clinical trial to determine if TAVR provides the same or more benefits with less risk in healthier “low-risk” patients. For more information about this trial, call 916.453.4575.